Shots: Celgene to get non-exclusive rights for Aprinoia’s bAPN-1607 and Aprinoia to receive license and usage fee annually The focus of the agreement is utilize Aprinoia’s APN-1607 in developing therapies […]readmore
Tags : Aprinoia